List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 183 studies with search of: Overactive Bladder Medications
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
Condition: Overactive Bladder
Interventions: Behavioral: Dietary Caffeine reduction;   Drug: Anticholinergic medication
2 Completed A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder
Condition: Overactive Bladder
Interventions: Drug: tolterodine tartrate;   Drug: Comparator: Placebo to tolterodine tartrate
3 Completed Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder
Condition: Urinary Incontinence
Interventions: Drug: Darifenacin;   Behavioral: Behavioral therapy
4 Recruiting A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.
Condition: Urinary Bladder, Overactive
Interventions: Drug: Placebo;   Drug: Fesoterodine fumarate
5 Completed The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder
Condition: Overactive Bladder
Intervention: Drug: DETROL LA (drug)
6 Completed Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.
Condition: Urinary Incontinence
Interventions: Drug: Tolterodine ER 4 mg QD;   Behavioral: OAB Patient Behavioral Training Material
7 Completed Use of Combined Anticholinergic Medication and Sacral Neuromodulation in the Treatment of Refractory Overactive Bladder
Condition: Overactive Bladder
Intervention: Other: Retrospective chart review
8 Recruiting Study of ONO-8539 in Patients With Overactive Bladder
Condition: Overactive Bladder
Interventions: Drug: Placebo;   Drug: Tolterodine;   Drug: ONO-8539
9 Recruiting Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients
Condition: Overactive Bladder
Intervention: Drug: Tolterodine
10 Completed Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder
Condition: Overactive Bladder
Interventions: Drug: Tolterodine & Pregabalin;   Drug: Tolterodine;   Drug: Placebo;   Drug: Pregabalin
11 Completed A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo
Condition: Overactive Bladder
Interventions: Drug: oxybutynin;   Other: placebo
12 Completed Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine ER in Patients With Overactive Bladder.
Condition: Overactive Bladder
Interventions: Drug: Tolterodine ER;   Drug: Placebo;   Drug: Fesoterodine
13 Completed Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder
Condition: Overactive Bladder
Interventions: Drug: Propiverine hydrochloride;   Drug: Placebo
14 Completed SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)
Condition: Overactive Bladder Syndrome (OABS)
Interventions: Drug: Placebo;   Drug: SMP-986
15 Enrolling by invitation Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease
Conditions: Parkinson's Disease;   Overactive Bladder
Intervention: Drug: Oxybutynin and darifenacin
16 Active, not recruiting A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder
Condition: Overactive Bladder
Interventions: Drug: KUC-7483;   Drug: Placebo;   Drug: Tolterodine
17 Completed
Has Results 		Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)
Condition: Overactive Bladder
Interventions: Drug: fesoterodine fumarate;   Drug: placebo;   Drug: tolterodine tartrate
18 Recruiting Assessment of Patient-Reported Goal Attainment in the Treatment of Female Overactive Bladder
Condition: Overactive Bladder
Interventions: Drug: Tolterodine extended-release (ER) 4mg;   Drug: Placebo
19 Completed
Has Results 		A Study To Assess If 10 mg Vardenafil (BAY 38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function
Conditions: Overactive Bladder;   Detrusor Overactivity
Interventions: Drug: Vardenafil HCl (Levitra, BAY38-9456);   Drug: Placebo
20 Completed SSR240600C Treatment in Women With Overactive Bladder
Condition: Overactive Bladder
Interventions: Drug: SSR240600C;   Drug: tolterodine;   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services